Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Neulasta articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
Amgen Shares Still Look Undervalued
... the launches of acute lymphoblastic leukemia drug Blincyto and a more convenient version of
(to defend against future biosimilar entrants) are already in progress. The biggest launch...
Read more at Morningstar
Food and Drug Administration
Amgen tops estimates with 51 percent spike in 1Q ...
... the revenue increase came from price increases. Sales were led by a flat $1.38 billion from
and Neupogen, for preventing infections in patients getting chemotherapy; rheumatoid...
Read more at
KOB 4 Albuquerque
+ 23 more articles
‘Be the Match’ event gives hope to former Grinnel...
... three surgeries, a needle biopsy, three bone marrow biopsies, a spinal tap and nine
shots, “which cause crippling bone pain for a few days,” he said. When mentioning the...
Read more at Marengo Pioneer Republican
Fidelity CEO taps personal fortune for bets on ca...
... have more than doubled since going public in November, is developing a biosimilar drug for
, a medicine that boosts the body's immune system during chemotherapy. Impresa owned...
Read more at Channel NewsAsia
U.S. Securities and Exchange Commission
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.